Research Associate with The Cameron Institute
Dr. Michael J. Rieder is a Professor of Paediatrics, Physiology & Pharmacology and Medicine at the University of Western Ontario. He holds the holds the CIHR-GSK Chair in Paediatric Clinical Pharmacology at the University of Western Ontario. He is also the Program Director of the Clinical Investigators Program and the Director of Paediatric Pharmacology at the University of Western Ontario and the Children’s Hospital of Western Ontario.
Dr. Rieder is also the Program Leader of the Children’s Optimal Therapeutics Program of the Child Health Research Institute at the University of Western Ontario. Dr. Rieder was born in St. Boniface, Manitoba and attended medical school at the University of Saskatchewan. Following medical school, Dr. Rieder did core training in Paediatrics at Wayne State University in the Children’s Hospital of Michigan in Detroit. Dr. Rieder then trained in Emergency Paediatrics and Paediatric Pharmacology at the Hospital for Sick Children in Toronto.
During this time, Dr. Rieder completed a Ph.D. in Biochemical Pharmacology under the supervision of Dr. S. Spielberg. Dr. Rieder moved to the University of Western Ontario in 1988. In recognition of his accomplishments in research he has been awarded the Leon Goldberg Young Investigator’s Award from the American Society for Clinical Pharmacology and Therapeutics, the KF Piafsky Award and the Senior Investigators Award from the Canadian Society of Clinical Pharmacology and a Fellowship from the Royal College of Physicians and Surgeons of Glasgow. Dr. Rieder has also won a Certificate of Merit from the Canadian Association of Medical Education and a Schulich Award of Excellence in Medical Education from the University of Western Ontario. Dr. Rieder has also been named as a Faculty Scholar at the University of Western Ontario.
Dr. Rieder serves as a consultant for the National Institutes of Health and the Canadian Institutes of Health Research. Dr. Rieder is certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Pediatrics. Dr. Rieder’s current research interests include studies of the mechanisms of adverse drug reactions, and on optimal therapy in children.Dr. Rieder is Chair of the Canadian Paediatric Society’s Committee on Drug Therapy and serves on the Scientific Program Committee of the Canadian Society of Pharmacology & Therapeutics.